Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2023-12-20 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
关于2024年度公司及子公司申请授信额度暨公司对子公司担保额度预计的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the application for credit limits and guarantees for its subsidiaries for the year 2024. It includes detailed information about the credit and guarantee amounts, the subsidiaries involved, their financial data, and the authorization process. The document is not a full financial report but rather a regulatory announcement about financing and guarantee activities. It does not contain comprehensive financial statements or quarterly/yearly financial results but focuses on credit and guarantee updates. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 4935 characters, which is sufficient for a detailed announcement but not a full report like an annual or interim report. Hence, the classification is CAP with high confidence.
2023-12-20 Chinese
关于公司独立董事辞职的公告
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the resignation of an independent director from the company's board. It details the resignation date, the director's roles, the impact on board composition, and the company's plan to fill the vacancy. There is no financial data, no mention of financial results, no regulatory filings about audits or reports, and no mention of shareholder votes or meetings. The content clearly relates to changes in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification with high confidence.
2023-12-13 Chinese
关于全资子公司完成工商注册登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration for a wholly-owned subsidiary of the company. It includes details about the subsidiary's name, registration number, legal representative, capital, address, and business scope. There is no financial data, no mention of financial results, no regulatory certifications, or voting results. The document is short (976 characters) and serves as a formal notification of a corporate event (subsidiary registration). This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2023-11-24 Chinese
关于对外投资设立全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's decision to invest in and establish a wholly-owned subsidiary. It details the board meeting resolution, investment purpose, company details of the new subsidiary, and compliance with stock exchange rules. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (1492 characters) and serves as a formal disclosure of a corporate action rather than a financial report or detailed management discussion. This fits the category of Capital/Financing Update (CAP), as it relates to the company's capital investment and structural changes through establishing a new subsidiary.
2023-11-20 Chinese
关于第四届董事会第三十五次（临时）会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board meeting resolution by the company 绿康生化股份有限公司. It details the convening of the fourth board's 35th (extraordinary) meeting, the approval of an investment to establish a wholly-owned subsidiary, and the voting results. There is no financial data, no detailed report, and no indication of an annual or interim report. The content focuses on board decisions and management authorization, which fits the category of Board/Management Information (MANG). The document length is short and it is a formal announcement of board resolutions, not a full report or presentation.
2023-11-20 Chinese
上海澄明则正律师事务所关于绿康生化股份有限公司2023年第四次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of procedures, attendance, and voting results of the 2023 fourth extraordinary general meeting of shareholders of a company. It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or financial performance data. It is a legal opinion related to a shareholders' meeting, focusing on the legality and validity of the meeting and voting process. This type of document is best classified as a Regulatory Filing (RNS) because it is a legal opinion related to corporate governance and shareholder meeting procedures, not a direct report like an Annual Report or Earnings Release, nor is it a simple announcement. It does not fit into categories like Board/Management Information or Declaration of Voting Results because it is a legal opinion letter rather than a direct announcement of voting results or management changes.
2023-11-14 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.